Manufacturing

Cerus

$7.26
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.03 (+0.41%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Cerus and other stocks, options, and ETFs commission-free!

About CERS

Cerus Corp. engages in the research, development, and manufacture of biomedical and surgical products. The firm produces blood system for platelets and plasma. It operates through Blood Safety segment. It markets products under the INTERCEPT brand. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA. The listed name for CERS is Cerus Corporation Common Stock.

CEO
William Mariner Greenman
Employees
254
Headquarters
Concord, California
Founded
1991
Market Cap
1.22B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.83M
High Today
$7.38
Low Today
$7.14
Open Price
$7.14
Volume
1.20M
52 Week High
$8.87
52 Week Low
$2.71

Collections

CERS Earnings

-$0.13
-$0.09
-$0.04
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Feb 18, After Hours

You May Also Like

HYXF
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure